Skip to main content
See every side of every news story
Published loading...Updated

FDA reviewing safety of abortion pill mifepristone

FDA reviews mifepristone safety after concerns from Republican attorneys general and Robert F. Kennedy Jr.; over two-thirds of U.S. abortions now use medication, experts say.

  • On September 29, 2025, the FDA announced a safety review of mifepristone, a drug used for medication abortions in the U.S. for 25 years.
  • The review was initiated in response to pressure by Republican state attorneys general and anti-abortion organizations opposing expanded access to the drug, particularly the use of telehealth since 2023.
  • Mifepristone, FDA-approved since 2000 to terminate pregnancies through 10 weeks, has been used by over 7.5 million women with a strong safety record confirmed by 100+ studies.
  • Kennedy's letter cited concerns from an EPPC study about risks without medical supervision, while CBS News quoted a medical expert noting serious complications occur in less than 1 in 200 cases.
  • The FDA review may lead to prescribing restrictions but experts consider an outright ban unlikely; the agency will keep states informed as it evaluates latest data and real-world evidence.
Insights by Ground AI

33 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 59% of the sources lean Right
59% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MSNBC broke the news in United States on Monday, September 29, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal